Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2009-05-11
2011-10-18
Lucas, Zachariah (Department: 1649)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S133100, C424S143100, C424S144100
Reexamination Certificate
active
08038992
ABSTRACT:
Methods are provided for decreasing demyelinating inflammatory disease in a subject by inhibiting the activity of chemokine-like receptor 1 (CMKLR1). Methods are also provided for screening for agents that find use in treating demyelinating inflammatory disease in a subject.
REFERENCES:
Graham et al., Clinical Immunology, vol. 123 (Supplement 1), May 10, 2007, abstract No. OR.91, p. S138.
Parolini et al., Blood, vol. 109, 2007, pp. 3625-3632.
Cash et al., J. Experimental Medicine, vol. 205, Apr. 7, 2008, pp. 767-775.
Butcher Eugene C.
Graham Kareem
Zabel Brian A.
Bozicevic Field & Francis LLP
Department of Veterans Affairs
Gucker Stephen
Lucas Zachariah
Sherwood Pamela J.
LandOfFree
Target for regulating multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Target for regulating multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Target for regulating multiple sclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4253550